News Quantified

SLDB – solid biosciences inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Solid Biosciences (SLDB) was downgraded by Wall Street Zen from "hold

Solid Biosciences to Participate at Upcoming Investor Conferences

Rett Syndrome Research Trust Appoints Genevieve Laforet, MD, PhD as Chief Medical Officer, Strengthening Leadership in Genetic Medicine Development

Solid Biosciences (SLDB) was upgraded by Truist Financial Corporation to "strong-buy".

Solid Biosciences (SLDB) had its price target raised by JPMorgan Chase & Co. from $11.00 to $12.00. They now have an "overweight" rating on the stock.

-1.3%

MISS

-15.3%

MISS

10.6%

BEAT

Form PRE 14A Solid Biosciences Inc. For: Jun 10

Form 8-K Solid Biosciences Inc. For: Apr 10

Form 4 Solid Biosciences Inc. For: Apr 02 Filed by: SMITH IAN F

Form EFFECT Solid Biosciences Inc.

Form EFFECT Solid Biosciences Inc.

Top News Gainers

7/26 Solid Biosciences Announces $60 Million Private Placement with New and Existing Investors 34.4%

8/16 Solid Biosciences Inc (NASDAQ: SLDB) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $10.00 price target on the stock. 33.5%

8/14 Solid Biosciences Reports Second Quarter 2019 Financial Results and Provides Business Update 23.8%

5/14 Solid Biosciences Inc (NASDAQ: SLDB) was downgraded by analysts at Chardan Capital from a "buy" rating to a "neutral" rating. They now have a $7.50 price target on the stock. 18.9%

10/11 Solid Biosciences Inc (NASDAQ: SLDB) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock. 11.2%

9/20 Solid Biosciences Inc (NASDAQ: SLDB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $12.00 price target on the stock. 11.2%

10/16 SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Solid Biosciences Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors 10.7%

7/29 Form 4 Solid Biosciences Inc. For: Jul 25 Filed by: Ganot Ilan 9.0%

8/27 Solid Biosciences Looks Like An Obvious Sell [Seeking Alpha] 8.7%

11/12 Solid Biosciences Inc (NASDAQ: SLDB) had its price target lowered by analysts at Credit Suisse Group AG from $6.00 to $2.00. They now have a "hold" rating on the stock. 7.4%

Top News Decliners

11/12 Solid Biosciences Provides SGT-001 Program Update -74.4%

5/13 Q1/2019 3/31/2019 EPS -0.850 ZacksConsensus -0.610 ActVsEst (0.240) - Miss -28.6%

3/13 Form 4 Solid Biosciences Inc. For: Mar 11 Filed by: Ziolkowski Jennifer Lynn -21.1%

12/18 Solid Biosciences stock are up on DMD study news [MarketWatch] -20.1%

1/9 Form 8-K Solid Biosciences Inc. For: Jan 07 -14.6%

3/23 Solid Biosciences Inc (NASDAQ: SLDB) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $5.00 price target on the stock. -9.3%

7/26 Form 8-K Solid Biosciences Inc. For: Jul 25 -9.2%

3/20 Solid Biosciences Inc (NASDAQ: SLDB) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -6.9%

8/29 Solid Biosciences Inc (NASDAQ: SLDB) was downgraded by analysts at Citigroup Inc from a "neutral" rating to a "sell" rating. They now have a $6.00 price target on the stock. -5.4%

7/31 Form D Solid Biosciences Inc. -5.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day